Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 3
2015 2
2020 2
2021 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
KM-408, a novel phenoxyalkyl derivative as a potential anticonvulsant and analgesic compound for the treatment of neuropathic pain.
Waszkielewicz A, Marona H, Pańczyk-Straszak K, Filipek B, Rapacz A, Sałat K, Kubacka M, Cios A, Fedak F, Walczak M, Hubicka U, Kwiecień A, Żuromska-Witek B, Szafrański PW, Koczurkiewicz-Adamczyk P, Pękala E, Przejczowska-Pomierny K, Pociecha K, Wyska E. Waszkielewicz A, et al. Among authors: zuromska witek b. Pharmacol Rep. 2023 Feb;75(1):128-165. doi: 10.1007/s43440-022-00431-7. Epub 2022 Nov 19. Pharmacol Rep. 2023. PMID: 36401763 Free PMC article.
Development and Validation of Stability-Indicating HPLC Methods for the Estimation of Lomefloxacin and Balofloxacin Oxidation Process under ACVA, H2O2, or KMnO4 Treatment. Kinetic Evaluation and Identification of Degradation Products by Mass Spectrometry.
Żuromska-Witek B, Żmudzki P, Szlósarczyk M, Maślanka A, Hubicka U. Żuromska-Witek B, et al. Molecules. 2020 Nov 11;25(22):5251. doi: 10.3390/molecules25225251. Molecules. 2020. PMID: 33187198 Free PMC article.
KM-416, a novel phenoxyalkylaminoalkanol derivative with anticonvulsant properties exerts analgesic, local anesthetic, and antidepressant-like activities. Pharmacodynamic, pharmacokinetic, and forced degradation studies.
Kubacka M, Rapacz A, Sałat K, Filipek B, Cios A, Pociecha K, Wyska E, Hubicka U, Żuromska-Witek B, Kwiecień A, Marona H, Waszkielewicz AM. Kubacka M, et al. Among authors: zuromska witek b. Eur J Pharmacol. 2020 Nov 5;886:173540. doi: 10.1016/j.ejphar.2020.173540. Epub 2020 Sep 5. Eur J Pharmacol. 2020. PMID: 32896552